GCAN
Greater Cannabis Company, Inc.
Next earnings ≈ Aug 17, 2026 · est. from filing cadence
$0.18
▲ 0.00%$0.18▲ +61166.67%
over 1Y
L $0.00EODHDH $0.45
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+0.0%
1W+24.2%
1M+26.8%
3M+6.6%
YTD-6.4%
1Y+61166.7%
Avoid
Conviction
Horizon
Medium (3–12mo)
High return on equity (44.7%); but revenue fell -73.7% YoY.
Revenue (FY2021) $12.6K · FY2021
Greater Cannabis Company, Inc. shows $12.6K in FY2021 revenue (-73.7% YoY), a -2625.6% net margin, and 44.7% ROE.
Financials · annual, by fiscal year
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $12.6K | — | — | — | — |
| Gross profit | -$25.00 | — | — | — | — |
| Operating income | -$343K | -$177K | -$175K | -$156K | -$183K |
| Net income | -$602K | -$360K | -$188K | -$179K | -$332K |
| Diluted EPS | — | $0.00 | $0.00 | $0.00 | $0.00 |
| Net margin | -4768.2% | — | — | — | — |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Key statistics
Valuation
Enterprise value$6.82K
EV / EBITDA—
EV / Sales0.5
EV / FCF—
P / FCF—
PEG (trailing)—
Earnings yield-190.9%
FCF yield—
Quality & risk
ROIC (est.)—
Free cash flow—
Total debt—
Net cash$167K
Altman Z-Score-10392.50 distress
Piotroski F-Score3/8
Capital returns
Buyback yield—
Dividend yield (est.)—
Shareholder yield—
Shares Δ YoY-99.9%
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Disclosure timeline
SEC · 8-Ks + reportsRed flag in recent filings — restated periodic report (2025-08-08). Worth a closer look.
Recent filings
all on EDGAR ↗10-QPeriod ending 2026-03-312026-05-13open ↗10-KPeriod ending 2025-12-312026-03-31open ↗10-QPeriod ending 2025-09-302025-11-12open ↗8-KPeriod ending 2025-10-222025-10-27open ↗8-K/APeriod ending 2025-10-152025-10-16open ↗8-KPeriod ending 2025-10-152025-10-15open ↗10-QPeriod ending 2025-06-302025-08-08open ↗10-Q/APeriod ending 2025-03-312025-08-08open ↗UPLOADFiling2025-05-22open ↗DEF 14CPeriod ending 2025-05-162025-05-16open ↗10-QPeriod ending 2025-03-312025-05-12open ↗PRE 14CPeriod ending 2025-05-062025-05-06open ↗
Frequently asked
- Is Greater Cannabis Company, Inc. (GCAN) a buy?
- GCAN currently carries a Avoid rating with 3/5 conviction, derived from its latest SEC filings. High return on equity (44.7%); but revenue fell -73.7% YoY.
- What is Greater Cannabis Company, Inc.'s quality score?
- GCAN scores 23.176470588235293/100 (grade F) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.
Sources: SEC EDGAR (CIK 0001695473, latest 10-Q filed 2026-05-13) · EODHD · as of 6/22/2026, 9:54:09 PM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.